retatrutide clinical trials results weight loss Results: 24% in 48 Weeks VisualAbstract: Retatrutide reduces body weight

Holmes advises medical providers on treatments like GLP-1s

Clinicians should stay informed on emerging data and consider GLP1s as part of a comprehensive liver and metabolic care plan

McClean PL, Hlscher C

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes Rachel Fieldhouse, Nature magazine Why Ozempic and Wegovy Might Change Some Peoples Favorite Foods Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why Lori Youmshajekian

The most common risk factor for adiposity was fast-food consumption, with 61.67% of individuals reporting it, followed by eating three meals per day (58.89%), a sedentary lifestyle (53.33%), sleeping time (44.22%), hypercaloric nutrition (43.56%), excessive alcohol consumption (42.89%), and depression symptoms (31.78%)

At Alchemy 43, we offer prescription medications like semaglutide and tirzepatide, which work by reducing hunger, improving insulin sensitivity, and helping the body burn excess fat